Skip to main content
Top
Published in: Metabolic Brain Disease 6/2023

Open Access 10-05-2023 | Original Article

Exome sequence analysis of rare frequency variants in Late-Onset Alzheimer Disease

Authors: Sudharsana Sundarrajan, Arthi Venkatesan, Udhaya Kumar S, Mohanraj Gopikrishnan, Iftikhar Aslam Tayubi, M Aditya, Gowrishankar Bychapur Siddaiah, C. George Priya Doss, Hatem Zayed

Published in: Metabolic Brain Disease | Issue 6/2023

Login to get access

Abstract

Alzheimer disease (AD) is a leading cause of dementia in elderly patients who continue to live between 3 and 11 years of diagnosis. A steep rise in AD incidents is observed in the elderly population in East-Asian countries. The disease progresses through several changes, including memory loss, behavioural issues, and cognitive impairment. The etiology of AD is hard to determine because of its complex nature. The whole exome sequences of late-onset AD (LOAD) patients of Korean origin are investigated to identify rare genetic variants that may influence the complex disorder. Computational annotation was performed to assess the function of candidate variants in LOAD. The in silico pathogenicity prediction tools such as SIFT, Polyphen-2, Mutation Taster, CADD, LRT, PROVEAN, DANN, VEST3, fathmm-MKL, GERP +  + , SiPhy, phastCons, and phyloP identified around 17 genes harbouring deleterious variants. The variants in the ALDH3A2 and RAD54B genes were pathogenic, while in 15 other genes were predicted to be variants of unknown significance. These variants can be potential risk candidates contributing to AD. In silico computational techniques such as molecular docking, molecular dynamic simulation and steered molecular dynamics were carried out to understand the structural insights of RAD54B with ATP. The simulation of mutant (T459N) RAD54B with ATP revealed reduced binding strength of ATP at its binding site. In addition, lower binding free energy was observed when compared to the wild-type RAD54B. Our study shows that the identified uncommon variants are linked to AD and could be probable predisposing genetic factors of LOAD.
Literature
go back to reference Agrahari AK, Kumar A, Silva R, Zayed H, Doss GPC (2018a) Substitution impact of highly conserved arginine residue at position 75 in GJB1 gene in association with X-linked Charcot-Marie-tooth disease: A computational study. J Theor Biol 437:305–317CrossRefPubMed Agrahari AK, Kumar A, Silva R, Zayed H, Doss GPC (2018a) Substitution impact of highly conserved arginine residue at position 75 in GJB1 gene in association with X-linked Charcot-Marie-tooth disease: A computational study. J Theor Biol 437:305–317CrossRefPubMed
go back to reference Agrahari AK, Muskan M, Doss CGP, Siva R, Zayed H (2018b) Computational insights of K1444N substitution in GAP-related domain of NF1 gene associated with neurofibromatosis type 1 disease: a molecular modeling and dynamics approach. Metab Brain Dis 33:1443–1457CrossRefPubMed Agrahari AK, Muskan M, Doss CGP, Siva R, Zayed H (2018b) Computational insights of K1444N substitution in GAP-related domain of NF1 gene associated with neurofibromatosis type 1 disease: a molecular modeling and dynamics approach. Metab Brain Dis 33:1443–1457CrossRefPubMed
go back to reference Agrahari AK, Doss GPC, Siva R, Magesh R, Zayed H (2019) Molecular insights of the G2019S substitution in LRRK2 kinase domain associated with Parkinson’s disease: A molecular dynamics simulation approach. J Theor Biol 469:163–171CrossRefPubMed Agrahari AK, Doss GPC, Siva R, Magesh R, Zayed H (2019) Molecular insights of the G2019S substitution in LRRK2 kinase domain associated with Parkinson’s disease: A molecular dynamics simulation approach. J Theor Biol 469:163–171CrossRefPubMed
go back to reference Ali SK, Sneha P, Priyadharshini Christy J, Zayed H, Doss CGP (2017) Molecular dynamics-based analyses of the structural instability and secondary structure of the fibrinogen gamma chain protein with the D356V mutation. J Biomol Struct Dyn 35:2714–2724CrossRefPubMed Ali SK, Sneha P, Priyadharshini Christy J, Zayed H, Doss CGP (2017) Molecular dynamics-based analyses of the structural instability and secondary structure of the fibrinogen gamma chain protein with the D356V mutation. J Biomol Struct Dyn 35:2714–2724CrossRefPubMed
go back to reference Al-Thani HF, Ahmad MN, Younes S, Zayed H (2021) Genetic Variants Associated With Alzheimer Disease in the 22 Arab Countries: A Systematic Review. Alzheimer Dis Assoc Disord 35:178–186CrossRefPubMed Al-Thani HF, Ahmad MN, Younes S, Zayed H (2021) Genetic Variants Associated With Alzheimer Disease in the 22 Arab Countries: A Systematic Review. Alzheimer Dis Assoc Disord 35:178–186CrossRefPubMed
go back to reference Andrade-Guerrero J, Santiago-Balmaseda A, Jeronimo-Aguilar P, Vargas-Rodríguez I, Cadena-Suárez AR, Sánchez-Garibay C et al (2023) Alzheimer’s Disease: An Updated Overview of Its Genetics. Int J Mol Sci 24(4):3754CrossRefPubMedPubMedCentral Andrade-Guerrero J, Santiago-Balmaseda A, Jeronimo-Aguilar P, Vargas-Rodríguez I, Cadena-Suárez AR, Sánchez-Garibay C et al (2023) Alzheimer’s Disease: An Updated Overview of Its Genetics. Int J Mol Sci 24(4):3754CrossRefPubMedPubMedCentral
go back to reference Bai F, Li T, Li B, Li X, Zhu L (2020) Serum Human Epididymis Protein 4 Level is Associated with Cognitive Function in Patients with Diabetes Mellitus. Diabetes Metab Syndr Obes 13:3919–3924CrossRefPubMedPubMedCentral Bai F, Li T, Li B, Li X, Zhu L (2020) Serum Human Epididymis Protein 4 Level is Associated with Cognitive Function in Patients with Diabetes Mellitus. Diabetes Metab Syndr Obes 13:3919–3924CrossRefPubMedPubMedCentral
go back to reference Bellenguez C, Grenier-Boley B, Lambert JC (2020) Genetics of Alzheimer’s disease: where we are, and where we are going. Curr Opin Neurobiol 61:40–48CrossRefPubMed Bellenguez C, Grenier-Boley B, Lambert JC (2020) Genetics of Alzheimer’s disease: where we are, and where we are going. Curr Opin Neurobiol 61:40–48CrossRefPubMed
go back to reference Blacker D, Tanzi RE (1998) The genetics of Alzheimer disease: current status and future prospects. Arch Neurol 55(3):294–296CrossRefPubMed Blacker D, Tanzi RE (1998) The genetics of Alzheimer disease: current status and future prospects. Arch Neurol 55(3):294–296CrossRefPubMed
go back to reference Doss GPC, Zayed H (2017) Comparative computational assessment of the pathogenicity of mutations in the Aspartoacylase enzyme. Metab Brain Dis 32:2105–2118CrossRef Doss GPC, Zayed H (2017) Comparative computational assessment of the pathogenicity of mutations in the Aspartoacylase enzyme. Metab Brain Dis 32:2105–2118CrossRef
go back to reference Harris JR (2012) Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease. Springer Science & Business Media Harris JR (2012) Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease. Springer Science & Business Media
go back to reference Izrailev S, Stepaniants S, Isralewitz B et al (1999) Steered Molecular Dynamics. In: Deuflhard P, Hermans J, Leimkuhler B et al (eds) Computational Molecular Dynamics: Challenges, Methods, Ideas. Springer, Berlin, Heidelberg, pp 39–65CrossRef Izrailev S, Stepaniants S, Isralewitz B et al (1999) Steered Molecular Dynamics. In: Deuflhard P, Hermans J, Leimkuhler B et al (eds) Computational Molecular Dynamics: Challenges, Methods, Ideas. Springer, Berlin, Heidelberg, pp 39–65CrossRef
go back to reference James NE, Chichester C, Ribeiro JR (2018) Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer. Front Oncol 8:124CrossRefPubMedPubMedCentral James NE, Chichester C, Ribeiro JR (2018) Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer. Front Oncol 8:124CrossRefPubMedPubMedCentral
go back to reference Liu C, Cui G, Zhu M et al (2014) Neuroinflammation in Alzheimer’s disease: chemokines produced by astrocytes and chemokine receptors. Int J Clin Exp Pathol 7:8342–8355PubMedPubMedCentral Liu C, Cui G, Zhu M et al (2014) Neuroinflammation in Alzheimer’s disease: chemokines produced by astrocytes and chemokine receptors. Int J Clin Exp Pathol 7:8342–8355PubMedPubMedCentral
go back to reference Miyashita A, Kikuchi M, Hara N, Ikeuchi T (2023) Genetics of Alzheimer’s disease: an East Asian perspective. J Hum Genet 68(3):115–124CrossRefPubMed Miyashita A, Kikuchi M, Hara N, Ikeuchi T (2023) Genetics of Alzheimer’s disease: an East Asian perspective. J Hum Genet 68(3):115–124CrossRefPubMed
go back to reference Vardarajan BN, Faber KM, Bird TD et al (2014) Age-specific incidence rates for dementia and Alzheimer disease in NIA-LOAD/NCRAD and EFIGA families: National Institute on Aging Genetics Initiative for Late-Onset Alzheimer Disease/National Cell Repository for Alzheimer Disease (NIA-LOAD/NCRAD) and Estudio Familiar de Influencia Genetica en Alzheimer (EFIGA). JAMA Neurol 71:315–323. https://doi.org/10.1001/jamaneurol.2013.5570CrossRefPubMedPubMedCentral Vardarajan BN, Faber KM, Bird TD et al (2014) Age-specific incidence rates for dementia and Alzheimer disease in NIA-LOAD/NCRAD and EFIGA families: National Institute on Aging Genetics Initiative for Late-Onset Alzheimer Disease/National Cell Repository for Alzheimer Disease (NIA-LOAD/NCRAD) and Estudio Familiar de Influencia Genetica en Alzheimer (EFIGA). JAMA Neurol 71:315–323. https://​doi.​org/​10.​1001/​jamaneurol.​2013.​5570CrossRefPubMedPubMedCentral
go back to reference Zhang JH, Tasaki T, Tsukamoto M, Wang KY, Kubo KY, Azuma K (2022) Deletion of Wnt10a Is Implicated in Hippocampal Neurodegeneration in Mice. Biomedicines 10(7):1500CrossRefPubMedPubMedCentral Zhang JH, Tasaki T, Tsukamoto M, Wang KY, Kubo KY, Azuma K (2022) Deletion of Wnt10a Is Implicated in Hippocampal Neurodegeneration in Mice. Biomedicines 10(7):1500CrossRefPubMedPubMedCentral
Metadata
Title
Exome sequence analysis of rare frequency variants in Late-Onset Alzheimer Disease
Authors
Sudharsana Sundarrajan
Arthi Venkatesan
Udhaya Kumar S
Mohanraj Gopikrishnan
Iftikhar Aslam Tayubi
M Aditya
Gowrishankar Bychapur Siddaiah
C. George Priya Doss
Hatem Zayed
Publication date
10-05-2023
Publisher
Springer US
Published in
Metabolic Brain Disease / Issue 6/2023
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-023-01221-7

Other articles of this Issue 6/2023

Metabolic Brain Disease 6/2023 Go to the issue